Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Current Liabilities -----

What is the latest Current Liabilities ratio of GLAND PHARMA ?

The latest Current Liabilities ratio of GLAND PHARMA is - based on Mar2026 Consolidated results.
Year Current Liabilities
Mar2026-
Mar2025-
Mar2024-
Mar2023-
Mar2022-

How is Current Liabilities of GLAND PHARMA Trending?

Years Current Liabilities % Change
Mar2026 -
0
Mar2025 -
0
Mar2024 -
0
Mar2023 -
0
Mar2022 - -

Compare Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹47,941.6 Cr 2.9% 19.7% 45.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.9%

19.7%

45.1%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses